Cintas (CTAS) director gets 503 RSUs, 1,694 options at $183.90
Cintas (CTAS) director Martin Mucci reported equity awards dated 10/29/2025.
Rhea-AI Filing Summary
Cintas (CTAS) director Martin Mucci reported equity awards dated 10/29/2025. He acquired 503 shares of common stock at $0 under the company’s 2016 Amended and Restated Equity and Incentive Compensation Plan; these restricted shares cliff vest on the first anniversary of the grant date.
He also received 1,694 stock options with an exercise price of $183.90, expiring on 10/29/2035; the option cliff vests after one year. Following the transactions, he beneficially owns 3,124 shares directly. The filing indicates the form was submitted for one reporting person.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 1,694 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 503 | $0.00 | $0.00 |
Footnotes (2)
- F1. Restricted shares granted pursuant to Cintas Corporation's 2016 Amended and Restated Equity and Incentive Compensation Plan. These shares cliff vest on the first anniversary of the grant date.
- F2. Options granted pursuant to Cintas Corporation's 2016 Amended and Restated Equity and Incentive Compensation Plan. The option cliff vests on the first anniversary of the grant date.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Cintas (CTAS) disclose on this Form 4?
What are the key terms of the CTAS stock options?
Who is the reporting person in the CTAS Form 4?
What plan governs these CTAS awards?
AI-generated analysis. How Rhea-AI works. Not financial advice.